Prof Kathleen Nicholls
Clinical (Professor)
Department of Medicine
302 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension
DOI: 10.1038/s41467-025-68256-52026
Journal article
Long-term effectiveness and safety outcomes in adults with Fabry disease treated with agalsidase alfa: 20 years of data from the Fabry Outcome Survey
DOI: 10.1111/eci.701422025
Journal article
Enhancing diagnostic outcomes in kidney genetic disorders: the KidGen national kidney genomics study protocol
DOI: 10.1186/s12882-024-03926-y2025
Journal article
Troponin rise in Fabry disease: an Australian perspective
DOI: 10.1111/imj.702312025
Journal article
Genetic Kidney Disease Across the Lifespan – Emerging Insights From Clinical Genomics in Older People
DOI: 10.1016/j.ekir.2025.06.0502025
Journal article
Two decades of experience of the Fabry Outcome Survey provides further confirmation of the long-term effectiveness of agalsidase alfa enzyme replacement therapy
DOI: 10.1016/j.ymgmr.2025.1012152025
Journal article
Sodium-glucose cotransporter 2 inhibitors reduce albuminuria in patients with Fabry disease: a real-world case series
DOI: 10.1111/imj.16603
RECENT SCHOLARLY WORKS
2025
Journal article
Fabry Disease Podocytes Reveal Ferroptosis as a Potential Regulator of Cell Pathology
DOI: 10.1016/j.ekir.2024.11.0242025
Journal article
Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing phase 1/2 study (STAAR)
DOI: 10.1016/j.ymgme.2024.1087732025
Journal article
Investigating lysosomal dysfunction in Fabry disease using induced pluripotent stem cell-derived podocytes
DOI: 10.20517/jtgg.2024.87